Sanara MedTech Inc. (SMTI) financial statements and ratios from SEC XBRL: revenue $103.12M (TTM), net margin -36.4%, revenue growth 19.0% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $103.12M |
| Net Margin | -36.4% |
| Revenue Growth (YoY) | 19.0% |
| EPS Growth (YoY) | 282.5% |
| FCF Growth (YoY) | -1041.1% |
| EV / EBITDA | 27.8 |
| Price / Book | 39.57 |
| Price / Sales | 2.85 |
| FCF Yield | -2.3% |
| DCF Value (model) | $7.13 |
| DCF Upside vs Price | -79.2% |
| Altman Z-Score | 3.36 (safe) |
| Piotroski F-Score | 4/9 |
| Sector P/E (Healthcare) | 21.6 |
SMTI overview · SMTI earnings · SMTI KPIs · SMTI investor relations · SMTI ownership · SMTI peers · SMTI filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.